Fab­ry dis­ease: FDA drafts drug de­vel­op­ment guid­ance

The FDA on Wednes­day is­sued draft guid­ance pro­vid­ing rec­om­men­da­tions to drug­mak­ers on clin­i­cal tri­al de­sign and el­i­gi­bil­i­ty cri­te­ria for prod­ucts to treat Fab­ry dis­ease. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER